Maximus MMS Business Segments
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Outside the U.S. | $568.88M-12.2% | $573.32M-14.0% | $599.89M-8.7% | $635.89M-2.0% | $647.76M+0.4% | |
| U.S. Services | $1.7B-7.1% | $1.73B-7.9% | $1.76B-7.7% | $1.8B-6.5% | $1.83B-3.6% | |
| Gross Profit by Business | ||||||
| Outside the U.S. | $89.12M-22.6% | $97.8M-14.4% | $111.7M+5.3% | $117.4M+16.8% | $115.18M+36.8% | |
| U.S. Services | $389.11M-11.2% | $400.37M-12.3% | $410.98M-14.3% | $423M-11.7% | $438.08M-4.0% | |
| Revenue by Product | ||||||
| Clinical Services | $2.18B+10.6% | $2.15B+11.3% | $2.1B+11.1% | $2.03B+14.3% | $1.97B+20.4% | |
| Employment & Other | $292.4M-31.6% | $311.38M-33.0% | $354.84M-24.4% | $397.41M-16.6% | $427.55M-13.6% | |
| Program Operations | $2.55B-3.2% | $2.6B-0.5% | $2.65B+3.1% | $2.66B+3.0% | $2.64B+1.3% | |
| Technology Solutions | $292.12M-18.7% | $309.93M-16.6% | $324.73M-13.4% | $346.07M-10.1% | $359.11M-8.4% | |
| Concentration Risk, Percentage by Product | ||||||
| Clinical Services | 122.5%+12.9pp | 118.9%+11.7pp | 113.6%+7.7pp | 112.7%-0.3pp | 109.6%+27.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Maximus break its business down?
- Maximus (MMS) reports revenue by business across 2 parts — Outside the U.S. and U.S. Services. Each is extracted from the segment footnotes and tracked over time.
- Where does Maximus's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Maximus's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
